Pulse Biosciences, Inc. PLSE Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s accrued liabilities, current?
- Pulse Biosciences, Inc. (PLSE) reported accrued liabilities, current of $5.41M in Q1 2026.
- How has Pulse Biosciences, Inc.'s accrued liabilities, current changed year-over-year?
- Pulse Biosciences, Inc.'s accrued liabilities, current increased by 35.7% year-over-year, from $3.98M to $5.41M.
- What is the long-term trend for Pulse Biosciences, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s accrued liabilities, current has grown at a -7.7% compound annual growth rate (CAGR), from $5.33M to $3.58M.